Cargando…
Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386073/ https://www.ncbi.nlm.nih.gov/pubmed/35990975 http://dx.doi.org/10.3389/fcvm.2022.987025 |
| _version_ | 1784769721346818048 |
|---|---|
| author | Du, Lixin Qin, Jiao Wang, Dengchuan Zhao, Yunhui Xu, Ning Wu, Chaowen |
| author_facet | Du, Lixin Qin, Jiao Wang, Dengchuan Zhao, Yunhui Xu, Ning Wu, Chaowen |
| author_sort | Du, Lixin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9386073 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93860732022-08-19 Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality Du, Lixin Qin, Jiao Wang, Dengchuan Zhao, Yunhui Xu, Ning Wu, Chaowen Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2022-08-04 /pmc/articles/PMC9386073/ /pubmed/35990975 http://dx.doi.org/10.3389/fcvm.2022.987025 Text en Copyright © 2022 Du, Qin, Wang, Zhao, Xu and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Cardiovascular Medicine Du, Lixin Qin, Jiao Wang, Dengchuan Zhao, Yunhui Xu, Ning Wu, Chaowen Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality |
| title | Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality |
| title_full | Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality |
| title_fullStr | Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality |
| title_full_unstemmed | Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality |
| title_short | Commentary: SGLT2is vs. GLP1RAs reduce cardiovascular and all-cause mortality |
| title_sort | commentary: sglt2is vs. glp1ras reduce cardiovascular and all-cause mortality |
| topic | Cardiovascular Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386073/ https://www.ncbi.nlm.nih.gov/pubmed/35990975 http://dx.doi.org/10.3389/fcvm.2022.987025 |
| work_keys_str_mv | AT dulixin commentarysglt2isvsglp1rasreducecardiovascularandallcausemortality AT qinjiao commentarysglt2isvsglp1rasreducecardiovascularandallcausemortality AT wangdengchuan commentarysglt2isvsglp1rasreducecardiovascularandallcausemortality AT zhaoyunhui commentarysglt2isvsglp1rasreducecardiovascularandallcausemortality AT xuning commentarysglt2isvsglp1rasreducecardiovascularandallcausemortality AT wuchaowen commentarysglt2isvsglp1rasreducecardiovascularandallcausemortality |